Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BB Biotech

BB Biotech?uq=XnI5dm0O
1993 FOUNDED
PUBLIC STATUS
BIOEE STOCK SYMBOL
65 INVESTMENTS
$49.44 SHARE PRICE (As of Tuesday Closing)
Description

Operator of an investment trust. The company's services include investing in biotech companies, operating in the areas of oncology, cardiovascular diseases and autoimmune diseases.

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Capital Markets/Institutions
Stock Exchange
SWX
Primary Office
  • Schwertstrasse 6
  • 8200 Schaffhausen
  • Switzerland

+41 052 000 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BB Biotech’s full profile, request a free trial.

BB Biotech Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$49.18 - $269.40 $3.71B $49.24 $12.61

BB Biotech Financials Summary

In Thousands,
USD
TTM
31-Dec-2017
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 3,628,515 3,628,515 3,217,382 3,355,181
Revenue 741,498 741,498 (775,471) 724,282
Net Income 698,285 698,285 (813,883) 678,744
Total Assets 3,734,561 3,734,561 3,166,641 4,192,128
Total Debt 97,527 97,527 201,213 161,871
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BB Biotech Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore BB Biotech‘s full profile, request access.

Request full access to PitchBook

BB Biotech Investments (65)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 01-Feb-2018 00000 00000 00 00000 Biotechnology
000000 00000000000 19-Oct-2017 0000 000.00 Biotechnology 000 0000000
000000 00000000000 01-Jun-2017 0000 Biotechnology 000 0000000
00000 06-Dec-2016 00000 00000 00 0000 Surgical Devices
Myovant Sciences 27-Oct-2016 IPO 00000 Biotechnology
To view this company’s complete investment and acquisition history, request access »

BB Biotech Exits (49)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 03-Sep-2015 00000 00000 00 000.00 Completed
  • 16 buyers
0000 000000000000 01-Aug-2014 00000 00000 00 00000 Completed
  • 11 buyers
0000 000000000000 11-Mar-2014 00000 00000 00 0000 Completed
  • 6 buyers
0000000000000 0000 03-Sep-2013 00000 00000 00 0000 Completed
  • 6 buyers
Kite Pharma 15-May-2013 Early Stage VC 0000 Completed
  • 7 buyers
To view this company’s complete exits history, request access »

BB Biotech Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore BB Biotech‘s full profile, request access.

Request full access to PitchBook

BB Biotech Executive Team (16)

Name Title Board
Seat
Contact
Info
Rudy Le Blanc Board Member & Managing Director
Claude Mikkelsen Director, Investor Relations
Maria-Grazia Iten-Alderuccio Director, Investor Relations
Felicia Flanigan Executive, Investment Management
Christian Koch Ph.D Executive, Investment Management Team

4 Former Executives

You’re viewing 5 of 16 executives. Get the full list »

BB Biotech Board Members (5)

Name Representing Role Since Contact
Info
00000 00000000 00.0 The Medicines Company Vice Chairman 000 0000
00000 00000000 00.0 Self Chairman & President 000 0000
00000 000000 00.0 Self Member of the Board of Directors 000 0000
0000 00 00000 BB Biotech Board Member & Managing Director 000 0000

1 Former Board Member

You’re viewing 4 of 5 board members. Get the full list »